#  @Biotechnerd1 BioPulse BioPulse posts on X about $xbi, $vktx, strong, key the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours. ### Engagements: [---] [#](/creator/twitter::1249816666621476865/interactions)  - [--] Week [---] -82% - [--] Month [-----] -79% - [--] Months [-------] -93% - [--] Year [----------] -42% ### Mentions: [--] [#](/creator/twitter::1249816666621476865/posts_active)  - [--] Month [--] -96% - [--] Months [---] +111% - [--] Year [---] +418% ### Followers: [-----] [#](/creator/twitter::1249816666621476865/followers)  - [--] Week [-----] no change - [--] Month [-----] +0.94% - [--] Months [-----] +29% - [--] Year [-----] +134% ### CreatorRank: [---------] [#](/creator/twitter::1249816666621476865/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) 28.04% [finance](/list/finance) 10.28% [cryptocurrencies](/list/cryptocurrencies) 4.67% [countries](/list/countries) 1.87% [currencies](/list/currencies) 1.87% [exchanges](/list/exchanges) 0.93% **Social topic influence** [$xbi](/topic/$xbi) #33, [$vktx](/topic/$vktx) #54, [strong](/topic/strong) 13.08%, [key](/topic/key) 8.41%, [$lly](/topic/$lly) 6.54%, [in the](/topic/in-the) 6.54%, [data](/topic/data) 6.54%, [$capr](/topic/$capr) 6.54%, [$urgn](/topic/$urgn) 5.61%, [$pgen](/topic/$pgen) 4.67% **Top accounts mentioned or mentioned by** [@wallstreet_dawg](/creator/undefined) [@seckennedy](/creator/undefined) [@maximusholla](/creator/undefined) [@sheffstation](/creator/undefined) [@kobeissiletter](/creator/undefined) [@62](/creator/undefined) [@100mg](/creator/undefined) [@pharmdca](/creator/undefined) [@classicequity](/creator/undefined) [@ripster47](/creator/undefined) [@duedoctor](/creator/undefined) [@martinshkreli](/creator/undefined) [@adamfeuerstein](/creator/undefined) [@vaxstolemyboy](/creator/undefined) [@oceanblues99](/creator/undefined) [@rpsagainsttrump](/creator/undefined) [@elaineywchen](/creator/undefined) [@vipshefftrades](/creator/undefined) [@50ma](/creator/undefined) [@scroogecapital](/creator/undefined) **Top assets mentioned** [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Eli Lilly and Company (LLY)](/topic/$lly) [Liquidia Corporation Common Stock (LQDA)](/topic/$lqda) [Novo-Nordisk (NVO)](/topic/$nvo) [Arcutis Biotherapeutics, Inc. (ARQT)](/topic/$arqt) [Day One Biopharmaceuticals, Inc. (DAWN)](/topic/$dawn) [Unicycive Therapeutics, Inc. (UNCY)](/topic/$uncy) [Mist (MIST)](/topic/$mist) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Pfizer, Inc. (PFE)](/topic/$pfe) [Structure Therapeutics Inc. (GPCR)](/topic/$gpcr) [Aligos Therapeutics, Inc. (ALGS)](/topic/$algs) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Biomea Fusion, Inc. (BMEA)](/topic/$bmea) [Soleno Therapeutics, Inc. Common Stock (SLNO)](/topic/$slno) [Synthetify (SNY)](/topic/$sny) [Nuvation Bio Inc. (NUVB)](/topic/$nuvb) [LENZ Therapeutics Inc (LENZ)](/topic/$lenz) [PTC Therapeutics, Inc. (PTCT)](/topic/$ptct) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [Amgen, Inc. (AMGN)](/topic/$amgn) [AstraZeneca PLC (AZN)](/topic/$azn) [Denali Therapeutics Inc. Common Stock (DNLI)](/topic/$dnli) [Cingulate Inc. (CING)](/topic/$cing) [Harmony Biosciences Holdings, Inc. (HRMY)](/topic/$hrmy) [Taraxa (TARA)](/topic/$tara) [Taysha Gene Therapies, Inc. (TSHA)](/topic/$tsha) [OS Therapies Incorporated (OSTX)](/topic/$ostx) [Kyverna Therapeutics, Inc. (KYTX)](/topic/$kytx) [Pharming Group N.V. (PHAR)](/topic/$phar) [Invivyd, Inc. (IVVD)](/topic/$ivvd) [Iovance Biotherapeutics, Inc. Common Stock (IOVA)](/topic/$iova) ### Top Social Posts Top posts by engagements in the last [--] hours "Key drivers of why $XAIR closed down 51% today.😑 do you agree [--]. Revenue Guidance Revised Lower: Lower Revenue Guidance FY [----] revenue guidance was revised down from $12-16 million to greater than $10 million signaling lower expected revenue growth. [--]. High Cash Burn and Financial Losses: - Increased Net Loss: The company reported a significant net loss of $60.2 million for FY [----] higher than the previous year's loss of $55.8 million. - High Cash Burn Rate: Adjusted cash burn for FY [----] was $46.2 million indicating substantial ongoing financial outflows. [--]. Capital Conservation Strategy:" [X Link](https://x.com/anyuser/status/1805734749845307757) 2024-06-25T22:48Z [----] followers, [----] engagements "Dip buy opportunity in $VKTX this morning on the shameless $PFE PR. Have to wonder about this management team - no details and clear pump. No wonder stock performance has been woeful Future is about safety/tolerability/ease of use - massive 🚩🚩when these details are not disclosed" [X Link](https://x.com/anyuser/status/1811394280117698927) 2024-07-11T13:37Z [----] followers, [---] engagements "WOW 👇 6.8% + this tolerability = huge win. $VKTX $VKTX Phase [--] Trial of Oral VK2735 in Healthy Subjects showing similar GI tolerability to placebo across all dose escalations up to 100mg 🔥 https://t.co/ht0m91gw9N $VKTX Phase [--] Trial of Oral VK2735 in Healthy Subjects showing similar GI tolerability to placebo across all dose escalations up to 100mg 🔥 https://t.co/ht0m91gw9N" [X Link](https://x.com/anyuser/status/1853252862886678943) 2024-11-04T01:48Z [----] followers, [----] engagements "Hugely important chart below for $VKTX investors and potentially the icing on the cake. If Im reading correctly the chart indicates that VK2735 not only induces significant weight loss(6.8% placebo adjusted @100mg) by Day [--] but also supports weight maintenance over the following [--] days (up to Date 57) without additional dosing. Strong 💪🏼💪🏼💪🏼 . $VKTX $XBI $LLY $NVO @Pharmdca $VKTX This is very good. Wt loss maintained long after last dose https://t.co/bCKhla2kEm $VKTX This is very good. Wt loss maintained long after last dose https://t.co/bCKhla2kEm" [X Link](https://x.com/anyuser/status/1853256868141117892) 2024-11-04T02:04Z [----] followers, [----] engagements "@ClassicEquity Higher net loss versus expectations but looks like its driven by a one off. Growth story here continues to over deliver (FY and Quarter)- Piper had a $40 price target on a lower revenue deliver versus what came in. Definitely an OPP here in the s**tty market. $DAWN" [X Link](https://x.com/anyuser/status/1894500032088277420) 2025-02-25T21:29Z [----] followers, [---] engagements "Ive been reflecting on Biotech ( $XBI ) and catalyst-driven trades year-to-date. Its stating the obvious but for 95% of Biotech investors buying and holding has been nothing short of a disaster. Unless you have infinite capital and can average in over timehoping that 40% of your trades eventually deliver 5x returnsyoull struggle. Thats the reality for most investors in this sector. Im planning to deploy an existing day trading technical system to enable sharper execution using the @ripster47 approach across Biotech and the broader market. Have reviewed recent $ tickers/my normal A+ setups and" [X Link](https://x.com/anyuser/status/1921638650854735991) 2025-05-11T18:48Z [----] followers, [----] engagements "$CING - another one I wish they would just get the offering/financing out of the way" [X Link](https://x.com/Biotechnerd1/status/1995950110631735776) 2025-12-02T20:16Z [----] followers, [---] engagements "A few Cantor high conviction names to add to your watchlist this year. I especially like the Cantor names to run-up into key catalysts $CABA $TARA $TSHA $TRVI $GPCR $HRMY Names to watch👀. Truthfully Im not convinced on $GPCR but doesnt mean it wont move into key catalysts. https://twitter.com/i/web/status/2009465845336924338 https://twitter.com/i/web/status/2009465845336924338" [X Link](https://x.com/Biotechnerd1/status/2009465845336924338) 2026-01-09T03:22Z [----] followers, [---] engagements "$ALGS - another micro cap to watch. Data on November 7th - has made big moves before" [X Link](https://x.com/Biotechnerd1/status/1975600768922350025) 2025-10-07T16:35Z [----] followers, [---] engagements "$UNCY - stating cash runway into [----]. Translation = theyve been tapping that ATM hard😂 Interesting one here once it settles. Top Watch today but it might sell off in the short term" [X Link](https://x.com/Biotechnerd1/status/2005612701930905954) 2025-12-29T12:11Z [----] followers, [---] engagements "$OSTX - going to raise cash before or after NDA filing Smart if they just get it done now. These names have been on 🔥when cash position is ok. Before After No Raise Before After No Raise" [X Link](https://x.com/Biotechnerd1/status/2009352727193899239) 2026-01-08T19:53Z [----] followers, [---] engagements "I sold $UNCY for a solid gain yesterday. Immediately regretted it and bought back this morning. Will add this on dips" [X Link](https://x.com/Biotechnerd1/status/2011814224637370531) 2026-01-15T14:54Z [----] followers, [---] engagements "$ARGX - curl watch on daily👀. Have been waiting to buy a starter in this one" [X Link](https://x.com/Biotechnerd1/status/2012151873898447344) 2026-01-16T13:16Z [----] followers, [---] engagements "$KYTX - another opportunity here IMO at this level" [X Link](https://x.com/Biotechnerd1/status/2016909161355743288) 2026-01-29T16:19Z [----] followers, [---] engagements "$PHAR - CRL" [X Link](https://x.com/Biotechnerd1/status/2018064477040623786) 2026-02-01T20:50Z [----] followers, [----] engagements "$IVVD - a lot of upside from here if the trial goes to plan + positive results. One to watch through 2026" [X Link](https://x.com/Biotechnerd1/status/2018682592271237423) 2026-02-03T13:46Z [----] followers, [---] engagements "Latest 💲 Long Positions in Order of Size(sharing high conviction only). Currently 30% ish cash. [--]. $VKTX - weight loss big bet. Have added more on any dips below $60. Added more today @62. Watch for surprise news of NASH partnership/spin off and expected weight loss benefit from oral candidate with favorable tolerability. [--]. $LXRX - Still a large spot. Made a solid move from $1.50. Not quite the run I was hoping for but more potential this week. Notes next week so dont hold unless you want to take risk through event. Took some gains. Also has data in Q125 communicated this week. [--]. $APLS -" [X Link](https://x.com/anyuser/status/1848864844776411325) 2024-10-22T23:11Z [----] followers, [----] engagements "$VKTX We think that monthly dosing is very feasible - data to support this to be included in upcoming poster. $XBI" [X Link](https://x.com/anyuser/status/1849193330418258056) 2024-10-23T20:57Z [----] followers, [----] engagements "$VKTX We did dose up to 100mg - we will leave results to poster. We look forward to getting the Phase [--] underway" [X Link](https://x.com/anyuser/status/1849194910907527565) 2024-10-23T21:03Z [----] followers, [----] engagements "There was never a recommendation to discontinue based on tolerability. 100mg. $VKTX $VKTX We did dose up to 100mg - we will leave results to poster. We look forward to getting the Phase [--] underway $VKTX We did dose up to 100mg - we will leave results to poster. We look forward to getting the Phase [--] underway" [X Link](https://x.com/anyuser/status/1849195457487962616) 2024-10-23T21:05Z [----] followers, [---] engagements "Latest YTD performance (95%+ Biotech Focused Trades Small/Mid Cap). Just 🙏🏻 for XBI / Biotech acceleration from November and catalyst trading gets very interesting at that point😌. $XBI #investingideas" [X Link](https://x.com/anyuser/status/1849936319616594317) 2024-10-25T22:09Z [----] followers, [----] engagements "$URGN - will be adding on this 50MA break if it can close well. Love this name into next year - Big Catalyst ahead" [X Link](https://x.com/Biotechnerd1/status/1851690558718414908) 2024-10-30T18:20Z [----] followers, [---] engagements "So if Im reading the charts correctly 100% of the 100mg cohort (n=9) achieved 5% weight loss. At a placebo adjusted loss of 6.8%. Home Run $VKTX $XBI" [X Link](https://x.com/anyuser/status/1853250762828107972) 2024-11-04T01:39Z [----] followers, [----] engagements "Is a picture available of the sub q poster $VKTX" [X Link](https://x.com/anyuser/status/1853264950757609827) 2024-11-04T02:36Z [----] followers, [---] engagements "$BBIO quick summary of Press Release this morning: ✅(Potential FDA approval imminent). Acoramidis (near complete TTR stabilizer for ATTR-CM): The ATTRibute-CM Phase [--] study demonstrated significant survival and quality-of-life improvements positioning it as a unique disease-modifying treatment in ATTR-CM. The NDA has been filed with a PDUFA date set for November [--] [----] signaling potential FDA approval. Upon approval the company will provide U.S. trial patients with lifelong access to acoramidis. ✅Encaleret for ADH1 has completed screening with enrollment completion expected by year-end." [X Link](https://x.com/anyuser/status/1856321533150433707) 2024-11-12T13:01Z [----] followers, [----] engagements "@DueDoctor $URGN $VKTX $ATRA(short term)" [X Link](https://x.com/anyuser/status/1857898519220335036) 2024-11-16T21:28Z [----] followers, [----] engagements "$BBIO Approved" [X Link](https://x.com/anyuser/status/1860113466763497763) 2024-11-23T00:09Z [----] followers, [----] engagements "$SAVA - corporate update tomorrow. Its a good thing for Biotech for this one to bite the dust. Many real companies with real pipelines with real potential - this is not one of them. 💀 imminent. $XBI" [X Link](https://x.com/anyuser/status/1860854252567957822) 2024-11-25T01:13Z [----] followers, [----] engagements "$SAVA #FAIL 🪦 - @MartinShkreli did his best to warn people and even the detailed work showing very clearly why it couldnt succeed. If you base your decisions on 1% what ifs in Biotech its the 100% guaranteed way to lose. $XBI" [X Link](https://x.com/anyuser/status/1861024744851607975) 2024-11-25T12:30Z [----] followers, 27K engagements "$APLT 👀 - there was a question of whether the cancelled Adcomm was good or bad. If bad they probably would have raised extra $$$ by now. Strong PDUFA run up is a positive indicator too. Could see a nice 20-30% pop on approval. Not a great cash runway(mid 2025) so I do expect a raise on approval. Circa $75-100mln. 👉As of September [--] [----] Applied Therapeutics reported the following cash position and financial details: ✅Cash Cash Equivalents and Short-Term Investments: $98.9 million ✅This represents a significant increase from $49.9 million as of December [--] [----]. Runway Assessment:" [X Link](https://x.com/Biotechnerd1/status/1861437512297681051) 2024-11-26T15:51Z [----] followers, [----] engagements "$APLT is going to crash hard. $2 likely. Credit to those who called out red flags and expected a CRL - market was completely off on this $XBI $APLT 👀 - there was a question of whether the cancelled Adcomm was good or bad. If bad they probably would have raised extra $$$ by now. Strong PDUFA run up is a positive indicator too. Could see a nice 20-30% pop on approval. Not a great cash runway(mid 2025) so I do expect a $APLT 👀 - there was a question of whether the cancelled Adcomm was good or bad. If bad they probably would have raised extra $$$ by now. Strong PDUFA run up is a positive" [X Link](https://x.com/anyuser/status/1861880790876872955) 2024-11-27T21:12Z [----] followers, [----] engagements "Bought a decent chunk of $IOVA here" [X Link](https://x.com/anyuser/status/1867238809877811558) 2024-12-12T16:03Z [----] followers, [----] engagements "$BMEA - quite a few red 🚩🚩🚩. Will post shortly" [X Link](https://x.com/Biotechnerd1/status/1869010945168797746) 2024-12-17T13:25Z [----] followers, [----] engagements "$BMEA 🚩🚩🚩🤮 Anytime I see sub-group analysis its almost always a massive short signal 😑 - Clinical hold disrupted dosing continuity. - Efficacy analysis limited to a smaller subgroup. - Results driven by specific subtypes (SIDD) rather than general T2D patients. - Moderate HbA1c reductions compared to competitors. - Limited understanding of long-term durability (12-week dosing). - Cash runway risk ahead of 52-week readout. $BMEA - quite a few red 🚩🚩🚩. Will post shortly. $BMEA - quite a few red 🚩🚩🚩. Will post shortly" [X Link](https://x.com/Biotechnerd1/status/1869015709142909149) 2024-12-17T13:44Z [----] followers, [----] engagements "🚨Reasons to like $PGEN🚨 ✅PDUFA Action date by June 30th 25👀 ✅Large recent insider buy $19mln👀 ✅Cash runway to [--] with recent PP👀 ✅High Private Equity & Institutional 💰👀 ✅Watch for 50MA close with volume👀 ✅Strong Analyst Coverage. JMP = $5👀 ✅Upside Downside. $1.50 likely👀 Definitely a strong run up contender into mid-2025 Can see this reaching $1.50-$2 pre PDUFA. $XBI Agree Yes 👍 Nope 👎 Yes 👍 Nope 👎" [X Link](https://x.com/anyuser/status/1873751396316557724) 2024-12-30T15:22Z [----] followers, [---] engagements "$ABEO - quite a de-risked PDUFA play into next year. Eyeing up an options trade on this one. Will share soon" [X Link](https://x.com/Biotechnerd1/status/1873770797481054539) 2024-12-30T16:39Z [----] followers, [---] engagements "$PGEN is on 🔥🔥🔥. $XBI 🚨Reasons to like $PGEN🚨 ✅PDUFA Action date by June 30th 25👀 ✅Large recent insider buy $19mln👀 ✅Cash runway to [--] with recent PP👀 ✅High Private Equity & Institutional 💰👀 ✅Watch for 50MA close with volume👀 ✅Strong Analyst Coverage. JMP = $5👀 ✅Upside 🚨Reasons to like $PGEN🚨 ✅PDUFA Action date by June 30th 25👀 ✅Large recent insider buy $19mln👀 ✅Cash runway to [--] with recent PP👀 ✅High Private Equity & Institutional 💰👀 ✅Watch for 50MA close with volume👀 ✅Strong Analyst Coverage. JMP = $5👀 ✅Upside" [X Link](https://x.com/anyuser/status/1873808771245629717) 2024-12-30T19:09Z [----] followers, [---] engagements "Final Year P&L from main account(95% + Biotech Trades). Best ever year in absolute $ value (not %😌). Happy in the context of an $XBI that has really underperformed again. 🤞🏽 next year we finally see 🎇. A lot of learnings to take into [----]. Some applied this year but as always can be much better. Making the most of the A+ setups / historically repeatable setups that consistently pay is the most important area for me to focus next year 👀👀. Latest YTD performance (95%+ Biotech Focused Trades Small/Mid Cap). Just 🙏🏻 for XBI / Biotech acceleration from November and catalyst trading gets" [X Link](https://x.com/anyuser/status/1873815261628756073) 2024-12-30T19:35Z [----] followers, [----] engagements "$VSTM - PDUFA confirmed for June 30th. Has about [--] months left of cash. Raise soon" [X Link](https://x.com/Biotechnerd1/status/1874967745240211496) 2025-01-02T23:55Z [----] followers, [---] engagements "$1 Billion Biotech PDUFA stocks institutional ownership ranked by % and absolute $$$. (source: Nasdaq) Important metric to consider in terms of the potential of the catalyst👀 ability to rebound from a sell the news reaction to an approval. Lower can also mean higher risk of CRL but not always true. Good news in that there are already a lot of solid PDUFA stock catalysts to look forward to in H1 [----] Few names I want to own after a deeper dive: $ABEO $ALDX $URGN $SCPH $KALV but keeping a close eye on all. $KALV 98% $URGN 86% $SCPH 74% $LENZ 68% $ABEO 66% $ALDX 62% $VSTM 60% $INDV 58% $MIST" [X Link](https://x.com/anyuser/status/1875546426999967767) 2025-01-04T14:14Z [----] followers, [---] engagements "$JSPR - went up 50% this morning before crashing $10. Safety issues and lack of detail driving the reaction Key 🚩🚩🚩 below: [--]. 🚩Small Sample Sizes Several cohorts (e.g. 240mg single-dose cohort) have very small sample sizes (N=3). While the data appears positive such small numbers limit the statistical significance and generalizability of results. Small sample sizes can exaggerate effects or underrepresent variability in outcomes. [--]. 🚩Lack of Placebo-Controlled Comparison in Some Data While some data comparisons to placebo are included other key data (e.g. durability of responses or" [X Link](https://x.com/Biotechnerd1/status/1876978773909774772) 2025-01-08T13:06Z [----] followers, [----] engagements "@Maximus_Holla Looks real but want to see PR by morning" [X Link](https://x.com/Biotechnerd1/status/1884742892159135921) 2025-01-29T23:18Z [----] followers, [---] engagements "$XFOR - heres the investor relations response on potential Reverse Split. The highlighted section was made by their IR team/ not me. Few ways of looking at this - [--]. Should get some clarity on RS by Feb 10th - near term risk here on this point [--]. If there is indeed a buyout offer possible this will be communicated in near term too given this deadline [--]. Also possibility of [---] day grace period as highlighted by Daniel Ferry in XFORs IR team below (most likely) $XBI" [X Link](https://x.com/anyuser/status/1886772253578420243) 2025-02-04T13:42Z [----] followers, [----] engagements "🚨 $SCPH - very cheap here. Under the radar and oversold. Could see 50% move over next [--] days👀🚨 CEO today with Oppenheimer: We feel really confident And. We are fully anticipating approval on March 6th Other key points: Investment Highlights: 1.Strong Commercial Launch of FUROSCIX Q4 [----] Revenue: $12.1M - $12.3M Full Year [----] Revenue: $36.1M - $36.3M 2.Strong Financial Position Cash & Cash Equivalents: $75.5M as of year-end [----] 3.Robust Patent Protection FUROSCIX Infusor: Patent until [----] SCP-111 Autoinjector: Patent until [----] 4.Long-Term Growth Initiatives Class IV Heart Failure: FDA" [X Link](https://x.com/anyuser/status/1889814597571400033) 2025-02-12T23:11Z [----] followers, [----] engagements "$DAWN - Q4 revenue of $29 million on the higher end of estimates. Not sure why stock is down right now. opportunity" [X Link](https://x.com/anyuser/status/1894495126317117452) 2025-02-25T21:10Z [----] followers, [----] engagements "$PHRRF - Q2 PDUFA and approval likely👀" [X Link](https://x.com/anyuser/status/1896547997766545817) 2025-03-03T13:07Z [----] followers, [---] engagements "$CAPR - exactly [--] days since BLA submission. News on Priority Review and PDUFA confirmation should be imminent👀. This one is cheap $XBI" [X Link](https://x.com/Biotechnerd1/status/1896549239309914571) 2025-03-03T13:12Z [----] followers, [----] engagements "$CAPR - BLA accepted with Priority Review August PDUFA - one to watch post carnage Should bounce strong off this news. $CAPR - exactly [--] days since BLA submission. News on Priority Review and PDUFA confirmation should be imminent👀. This one is cheap $XBI $CAPR - exactly [--] days since BLA submission. News on Priority Review and PDUFA confirmation should be imminent👀. This one is cheap $XBI" [X Link](https://x.com/Biotechnerd1/status/1896894777121194161) 2025-03-04T12:05Z [----] followers, [----] engagements "$PHRRF - PDUFA of June 4th. Could be interesting here from capitulation levels" [X Link](https://x.com/anyuser/status/1899432082616553958) 2025-03-11T12:07Z [----] followers, [---] engagements "Having a nibble here this morning - top picks for a move: $KALV $CAPR $VSTM $URGN $MIST $ABEO $PHRRF(lottery) $XBI - time for a bounce 🙏🏻" [X Link](https://x.com/anyuser/status/1899820445886562385) 2025-03-12T13:51Z [----] followers, [----] engagements "$CAPR will take off soon. Key from earnings: cash balance of approximately $152 million at year-end [----] expected to support current planned operations into [----] - huge priority review PDUFA catalyst for the company in August. Really like the entry at these levels. Prediction: despite the shit market this will at least hit its [--] week high($23.40) prior to the event. Long $XBI" [X Link](https://x.com/Biotechnerd1/status/1902480528995185135) 2025-03-19T22:01Z [----] followers, [----] engagements "Fk it - added more $ABEO. Really think this is a bargain here - approval incoming and it could come early. $XBI" [X Link](https://x.com/Biotechnerd1/status/1904907757611823531) 2025-03-26T14:46Z [----] followers, [---] engagements "Ive added to my $SLNO position. Approval likely so sold some Puts ahead of decision - will take nice premium if this goes as expected. Also added stock in rollover.🤞🏽 could be pivot time for $XBI. I will remain optimistic despite the carnage - this is when the real opportunities emerge. 😂😂" [X Link](https://x.com/anyuser/status/1904938746669064444) 2025-03-26T16:49Z [----] followers, [----] engagements "$50k starter in $VKTX. Way way off highs. This should run into P2 data. News was positive this morning" [X Link](https://x.com/anyuser/status/1904942837600317938) 2025-03-26T17:05Z [----] followers, [---] engagements "$PHRRF - still very under the radar. +RFK this could get some Press attention next few months. Worth watching. I do hold a long spot. PDUFA upcoming" [X Link](https://x.com/anyuser/status/1905271431773987066) 2025-03-27T14:51Z [----] followers, [----] engagements "$CAPR - another buying opportunity here. This is going higher eventually. Cantor Reiterates Maintains $30 PT $CAPR & HCW at $77 PT. PDUFA Aug [--]. OLE study to be used for label extension. In NON-AMBULATORY patients there has been sig progress (n=12) imo. Nippon partnership in US Japan and Europe. I'm figureing 100M in milestones on approval in Cantor Reiterates Maintains $30 PT $CAPR & HCW at $77 PT. PDUFA Aug [--]. OLE study to be used for label extension. In NON-AMBULATORY patients there has been sig progress (n=12) imo. Nippon partnership in US Japan and Europe. I'm figureing 100M in" [X Link](https://x.com/Biotechnerd1/status/1905292250373816437) 2025-03-27T16:14Z [----] followers, [----] engagements "$MIST leak - I dont see anything yet on wires" [X Link](https://x.com/anyuser/status/1905350779726098788) 2025-03-27T20:06Z [----] followers, [----] engagements "$MIST - circa $1.30 cash per share. This one is going to fall hard today. An opportunity in the future when they sort out CMC issues but not in the immediate term - would avoid" [X Link](https://x.com/anyuser/status/1905580240778277233) 2025-03-28T11:18Z [----] followers, [----] engagements "📣Summary of where we are with $SWTX $XBI + The Unknowns👀 ex Merck K. [--] weeks since the Merck letter. Normally I would think thats a bad thing but in this case I think it may in fact be a good thing Strong likelihood of multiple parties involved IMO. Note: ✅Key Positive Indicators of a Multi-Bidder Scenario -Merck Confirmed Talks Publicly (Feb 10): -Merck KGaA acknowledged active acquisition discussions with SpringWorks. -The company confirmed no binding deal had been signed leaving room for competition. ✅Strong Strategic Appeal: -SpringWorks has two FDA-approved drugs: Ogsiveo (desmoid" [X Link](https://x.com/anyuser/status/1905771466106523834) 2025-03-28T23:58Z [----] followers, [----] engagements "$ALDX here we go. please be + and on time🙏🏻" [X Link](https://x.com/Biotechnerd1/status/1907522805098221927) 2025-04-02T19:57Z [----] followers, [----] engagements "@KobeissiLetter April 9th Liberation Day:" [X Link](https://x.com/Biotechnerd1/status/1908894357433839946) 2025-04-06T14:47Z [----] followers, 10.7K engagements "@adamfeuerstein What time do the Boston bars open" [X Link](https://x.com/Biotechnerd1/status/1909010211509051505) 2025-04-06T22:27Z [----] followers, [----] engagements "@SecKennedy So will you encourage American families to get vaccinated so this doesnt happen" [X Link](https://x.com/Biotechnerd1/status/1909049326736748969) 2025-04-07T01:03Z [----] followers, 26.6K engagements "@VaxStoleMyBoy @SecKennedy I think he needs to be more explicit and not reactive only to death- its already too late for many" [X Link](https://x.com/Biotechnerd1/status/1909053886356168942) 2025-04-07T01:21Z [----] followers, [---] engagements "@OceanBlues99 @SecKennedy Not that you are going to listen but facts still matter Unvaccinated people are: 20x more likely to be hospitalized 10x more likely to die from measles The number of loony toons in this chat feed says it all" [X Link](https://x.com/Biotechnerd1/status/1909056455665233980) 2025-04-07T01:31Z [----] followers, [----] engagements "@RpsAgainstTrump Winning - The Made in America Trump Calculator for Sale Soon" [X Link](https://x.com/Biotechnerd1/status/1909131999031214382) 2025-04-07T06:31Z [----] followers, [----] engagements "Would keep an eye on $ALGS / looking for a nice strong Green volume candle. Last time this led to a large momentum move higher. From capitulation levels even a fraction of this would be good. Low floater with catalysts ahead WAY below cash. Good R:R here.$XBI" [X Link](https://x.com/anyuser/status/1914758455526674939) 2025-04-22T19:09Z [----] followers, [---] engagements "$SGMO - one to watch with strong analyst coverage & $LLY factor. Its down so much after hours because of offering and limited 💵 runway. Possibly an interesting oversold bounce play tomorrow with data catalyst upcoming. They will need more financing before BLA filing - strength of that comes down to data 🧑🔬Fabry Disease (Lead Program): All patients in Phase 1/2 STAAR trial (isaralgagene civaparvovec) have completed the 52-week FDA-required follow-up. Positive eGFR trends maintained; well tolerated. Productive CMC meeting with FDA in April [----]. Target BLA submission: Q1 [----] Potential" [X Link](https://x.com/anyuser/status/1922058811516277149) 2025-05-12T22:38Z [----] followers, [----] engagements "Yikes $SGMO - no floor 😱 $SGMO - one to watch with strong analyst coverage & $LLY factor. Its down so much after hours because of offering and limited 💵 runway. Possibly an interesting oversold bounce play tomorrow with data catalyst upcoming. They will need more financing before BLA filing - $SGMO - one to watch with strong analyst coverage & $LLY factor. Its down so much after hours because of offering and limited 💵 runway. Possibly an interesting oversold bounce play tomorrow with data catalyst upcoming. They will need more financing before BLA filing -" [X Link](https://x.com/Biotechnerd1/status/1922060287034691830) 2025-05-12T22:44Z [----] followers, [----] engagements "This is actually very bullish for $VKTX - right - $NVO planning to fork out 2.2bln. $VKTX sitting at a 3.1bln market cap and at completely different advanced development stage On watch today Novo Nordisk $NVO strikes deal with Septerna $SEPN to develop obesity pills https://t.co/95Ixvy9Ywr via @elaineywchen Novo Nordisk $NVO strikes deal with Septerna $SEPN to develop obesity pills https://t.co/95Ixvy9Ywr via @elaineywchen" [X Link](https://x.com/anyuser/status/1922617607871508657) 2025-05-14T11:38Z [----] followers, [----] engagements "🚨 $URGN - Docs Out. Summary Whats the view here - trial design a big issue Key Positives ✅ Strong Efficacy 77.6% CRR at [--] months 79% maintained response at [--] months 🧓 Patient Preference Older/comorbid patients prefer UGN-102 over TURBT Less invasive office-based treatment 🏥 In-Office Option Offers non-surgical alternative Reduces anesthesia risk Key Negatives ⚠ No Control Arm Single-arm ENVISION trial = weak comparative data Hard to separate drug effect from natural history ❌ Incomplete PRO Data Patient-reported urinary symptoms not robustly captured FDA says timing/methods flawed 💉" [X Link](https://x.com/Biotechnerd1/status/1923357294764408992) 2025-05-16T12:38Z [----] followers, [----] engagements "🚨Part [--] - Latest PDUFA/Adcomm dates [--] days 👀. Note - I always like to prioritize based on timing. Especially when the $XBI is weak $NVAX - Approved this weekend $URGN AdComm May [--] $ARQT May [--] $SNY May [--] $LQDA May [--] $ETON May [--] $MRNA May [--] $MRK June [--] $MRNA June [--] $URGN June [--] $GILD June [--] $REGN $SNY June [--] $MRK June [--] $NUVB June [--] $UNCY June [--] $REGN July [--] $AZN $DSNKY July [--] $REPL July [--] $GSK July [--] $ASND July [--] $APLS July [--] $REGN $ZLAB July 30" [X Link](https://x.com/anyuser/status/1924194729937293652) 2025-05-18T20:05Z [----] followers, [----] engagements "🚨Part [--] [--]. For missing $ tickers please comment 🙏🏻: $GRPH $LENZ $PHRRF Aug [--] [--] $INSM Aug [--] $TNXP Aug [--] $CMRX $ABEO $RARE Aug [--] $PTCT Aug [--] $IONS $THTX Aug [--] $PGEN Aug [--] $OTLK Aug [--] $SNY Aug [--] $CAPR Aug [--] $BIIB Aug [--] $AGIO - Sep 7th $BCRX Sep [--] $SRRK Sep [--] $MRK - Sep [--] $OMER Sep [--] $CRNX - Sep [--] $FBIO Sep [--] $ARQT Oct [--] $AMGN $AZN Oct [--] $GKOS Oct [--] $RHHBY Oct [--] $RGNX Nov [--] $ARWR Nov [--] $AMGN Dec [--] $CYTK Dec [--] $CORT Dec [--] $VNDA Dec [--] $TVTX Jan [--] $VNDA Feb [--] $BHVN AdComm + PDUFA Q4 2025+ (TBD)" [X Link](https://x.com/anyuser/status/1924202224479080581) 2025-05-18T20:35Z [----] followers, [----] engagements "$REPL - one to watch. July PDUFA - no Adcomm" [X Link](https://x.com/Biotechnerd1/status/1925532201120047565) 2025-05-22T12:40Z [----] followers, [----] engagements "$ARQT approved" [X Link](https://x.com/anyuser/status/1925616808079327432) 2025-05-22T18:16Z [----] followers, [---] engagements "📚Weekend PDUFA Homework 📚 Action Packed Catalyst Filled YTG with XBI near lows. Cant remember so many PDUFAs Caution needed in short term but there are names below that will 2X + pre catalyst. Need to find them👀. $XBI $IBB Please point out any gaps or ideas" [X Link](https://x.com/Biotechnerd1/status/1926633391685824903) 2025-05-25T13:36Z [----] followers, [----] engagements "Here are the ➕📈 Momentum names bucking the sector trend from this list. As you can imagine its short 😂. Only names Id be comfortable buying and holding right now over few months. With stops at key support If we see a rocky few weeks these could be very good names to buy. 🟢 $CORT 🟢 $BCRX 🟢 $DSNKY 🟢 $GILD 🟢 $ASND 🟢 $ZLAB 🟢 $LENZ 🟢 $TNXP 🟢 $ABEO 🟢 $THTX $XBI $IBB 📚Weekend PDUFA Homework 📚 Action Packed Catalyst Filled YTG with XBI near lows. Cant remember so many PDUFAs Caution needed in short term but there are names below that will 2X + pre catalyst. Need to find them👀. $XBI" [X Link](https://x.com/Biotechnerd1/status/1926658977737105833) 2025-05-25T15:17Z [----] followers, [----] engagements "Here is my Bounce List - names that could reverse soon and bounce in a green-flat $XBI 👀 🟧 $SRRK 🟧 $KALV 🟧 $AZN 🟧 $PHRRF 🟧 $PTCT 🟧 $IONS 🟧 $PGEN 🟧 $ARQT 🟧 $CHRS 🟧 $ARWR Not justified in technicals right now but could reverse soon: 🟧 $FBIO 🟧 $ICCM 🟧 $OTLK 🟧 $CAPR 🟧 $NUVB 🟧 $VNDA Here are the ➕📈 Momentum names bucking the sector trend from this list. As you can imagine its short 😂. Only names Id be comfortable buying and holding right now over few months. With stops at key support If we see a rocky few weeks these could be very good names to buy. Here are the ➕📈 Momentum" [X Link](https://x.com/anyuser/status/1926709113968263197) 2025-05-25T18:37Z [----] followers, [----] engagements "Well thats a penetration rate to get excited about 📈🚀. $LLY $NVO $AMGN $PFE $VKTX $ZEAL $GPCR $RHHBY https://apple.news/AjTxTTEAWTDuh1Hk0iHw92g https://apple.news/AjTxTTEAWTDuh1Hk0iHw92g" [X Link](https://x.com/anyuser/status/1926834084317122800) 2025-05-26T02:53Z [----] followers, 24.6K engagements "@KobeissiLetter Current Priority:" [X Link](https://x.com/Biotechnerd1/status/1927088770815263189) 2025-05-26T19:45Z [----] followers, [----] engagements "To state the obvious $URGN approval is extremely bullish for PDUFA catalyst trades this year" [X Link](https://x.com/Biotechnerd1/status/1933230326597173708) 2025-06-12T18:30Z [----] followers, [---] engagements "@Maximus_Holla Love $LRMR in particular - only a matter of time for this to 🚀" [X Link](https://x.com/Biotechnerd1/status/1935369100613796108) 2025-06-18T16:08Z [----] followers, [----] engagements "Few challenges and keen to hear your thoughts. First below are some recent examples of late cycle deficiency letters that resulted in a CRL: Ascendis Pharma TransCon PTH (Hypoparathyroidism) Deficiency Letter: April [--] [----] PDUFA: April [--] [----] ❌ CRL issued Reason: Manufacturing/CMC issues with dose variability control; no clinical problems Type: NDA (Biologic) Phathom Pharma Vonoprazan (Erosive GERD) Deficiency Letter: January [--] [----] PDUFA: January [--] [----] ❌ CRL issued Reason: Nitrosamine impurity in tablets (CMC); no efficacy issues Type: NDA (Small molecule) Lexicon Pharmaceuticals" [X Link](https://x.com/anyuser/status/1939009203676295384) 2025-06-28T17:13Z [----] followers, [---] engagements "$VKTX - finally break of [--] today" [X Link](https://x.com/anyuser/status/1942586585628995673) 2025-07-08T14:08Z [----] followers, [---] engagements "$REVB securities lending rate at Schwab. 62% 🤯. I dont know who in the world would want to short a sub 600k float micro cap stock with a near term data catalyst. Good in terms of squeeze potential.@VIPSheffTrades @SheffStation fyi. $XBI" [X Link](https://x.com/anyuser/status/1943313730944528427) 2025-07-10T14:17Z [----] followers, [----] engagements "$PGEN - another upcoming PDUFA under CBER that ran a single arm trial. Would exercise caution on this one now based on $REPL CRL" [X Link](https://x.com/anyuser/status/1947618828822708255) 2025-07-22T11:24Z [----] followers, [----] engagements "$VKTX earnings tomorrow Should be a good clearing event ahead of their data - could make a nice move from tm" [X Link](https://x.com/Biotechnerd1/status/1947629011880055027) 2025-07-22T12:05Z [----] followers, [----] engagements "$VKTX - data run up going to be good with this one" [X Link](https://x.com/anyuser/status/1948738478268727577) 2025-07-25T13:33Z [----] followers, [---] engagements "Make that [--] big flushes - I did ⛔. $IXHL Two big flushes here [--]. On the unhalt from [----] [--]. On the open from [----]. Looks like it could go lower from here but risk reward not there anymore for me. $IXHL Two big flushes here [--]. On the unhalt from [----] [--]. On the open from [----]. Looks like it could go lower from here but risk reward not there anymore for me. $IXHL" [X Link](https://x.com/Biotechnerd1/status/1950566557953724513) 2025-07-30T14:38Z [----] followers, [----] engagements "LOL 🤡🤡🤡 $IXHL $XBI Hey folks we have been actively screwing you since yesterday but dont worry we wont utilize the *FULL* $100mln Make that [--] big flushes - I did ⛔. $IXHL Make that [--] big flushes - I did ⛔. $IXHL" [X Link](https://x.com/anyuser/status/1950890411855151302) 2025-07-31T12:04Z [----] followers, [----] engagements "$LLY - this drop way overdone👀. Funny close to a $100bln drop in market cap. Sure they could just buy $VKTX for a rounding error and their market cap would recover/go higher😂" [X Link](https://x.com/anyuser/status/1953407507155583416) 2025-08-07T10:46Z [----] followers, [----] engagements "Good Morning🌅 Top [--] Watch for me today👀 $VKTX - oral data soon & $LLY 🤢 pill data $GILD - 💪🏼 earnings. New ATH $CYTK - @50MA. Post earnings. Could push now. PDUFA December. $NVO - oversold bounce. $ETON - big move already PM but strong momentum name in the past. $SRRK - PDUFA Sept 22nd. Oversold. $KURA - Earnings Clearing Event. Multiple Catalysts ahead including PR PDUFA. $LLY - watching. Could go either way - think this bounces soon. $AKRO - no buyout. May sell off. $IOVA - will likely be a big mover either way on open. New ATL $XBI $IBB" [X Link](https://x.com/anyuser/status/1953779969802318281) 2025-08-08T11:26Z [----] followers, [----] engagements "$LQDA - super strong. Has blown past expectations - a lot of upside. I was skeptical here for a while. Follow the numbers . this one should do well👀" [X Link](https://x.com/Biotechnerd1/status/1955217440843108621) 2025-08-12T10:38Z [----] followers, [----] engagements "Just to put this into perspective I think $LQDA have hit circa 90% of Oppenheimers total expectation in11 weeks. The upper analyst targets of $40 + look very realistic now.upgrades should follow. $XBI $LQDA YUTREPIA surpasses [---] unique patient prescriptions and [---] patient starts within [--] weeks after approval to treat PAH and PH-ILD https://t.co/sZdo9fucDa $LQDA YUTREPIA surpasses [---] unique patient prescriptions and [---] patient starts within [--] weeks after approval to treat PAH and PH-ILD https://t.co/sZdo9fucDa" [X Link](https://x.com/Biotechnerd1/status/1955220960774115572) 2025-08-12T10:52Z [----] followers, [----] engagements "Buying a starter here pre market @$22.80. Want to see open but this could do very well today. $LQDA Just to put this into perspective I think $LQDA have hit circa 90% of Oppenheimers total expectation in11 weeks. The upper analyst targets of $40 + look very realistic now.upgrades should follow. $XBI Just to put this into perspective I think $LQDA have hit circa 90% of Oppenheimers total expectation in11 weeks. The upper analyst targets of $40 + look very realistic now.upgrades should follow. $XBI" [X Link](https://x.com/Biotechnerd1/status/1955227921594863856) 2025-08-12T11:20Z [----] followers, [----] engagements "@scroogecapital The management /execution did indeed change my mind - check my feed. Ive been bullish on this for a while. also clearly as a long term short idea I was wrong - so wrong I went long myself and posted as such. no issues admitting when Im wrong 😌 $LQDA" [X Link](https://x.com/Biotechnerd1/status/1955287988973273185) 2025-08-12T15:19Z [----] followers, [---] engagements "$TNXP - where is the news" [X Link](https://x.com/Biotechnerd1/status/1956311788426822128) 2025-08-15T11:07Z [----] followers, [----] engagements "$TNXP $60 - $14 - back over $40😂😂 I did say today would be fun. $TNXP - where is the news $TNXP - where is the news" [X Link](https://x.com/Biotechnerd1/status/1956312524279693550) 2025-08-15T11:10Z [----] followers, [----] engagements "Bio Catalyst names going to be 🔥 - with rate cuts coming. This has happened before" [X Link](https://x.com/Biotechnerd1/status/1958893459021988152) 2025-08-22T14:06Z [----] followers, [---] engagements "Good Morning 🌅 - heres my top [--] focus Biotech names for today: $OTLK - Decision day. Pop & Drop watch if approved. $GRCE - PDUFA April [----]. $SLNO - Bounce watch off MA. Like this to make a big move soon. $LLY - Oral Submission coming. Huge catalyst. $LRMR - Data [--] days. $CRNX - PDUFA [--] days. $AGIO - PDUFA [--] days. $MNKD - Oversold. Volume Pre Market $DAWN - Turnaround story from slow start A lot of upside if management deliver. $CYTK - PDUFA top Watch. Others Im keeping an eye on: $XFOR $BBIO $BHVN $LQDA. Short: $BTAI(its mostly played out pre market) $TNXP (classic post approval fade)" [X Link](https://x.com/anyuser/status/1960689016031912365) 2025-08-27T13:01Z [----] followers, [----] engagements "$KURA $CYTK $SNDX $TVTX - top PDUFA catalyst picks 😍" [X Link](https://x.com/anyuser/status/1961067427732533737) 2025-08-28T14:04Z [----] followers, [----] engagements "$CYTK - that inevitable buyout rumor will drop sometime soon. Probably pushes it over $60 when that happens. Also a good entry here. Very very de risked now moving forward. $XBI" [X Link](https://x.com/anyuser/status/1963660399397523942) 2025-09-04T17:48Z [----] followers, [----] engagements "I really like $ALDX as a bounce play from $4. Extension and should get approval. 50% upside into PDUFA" [X Link](https://x.com/anyuser/status/2008577272044007593) 2026-01-06T16:31Z [----] followers, [----] engagements "$VERA touched [--] a pre market ATH - up well over 100% from that silly dip to [--] a few months back. $VERA - will be a top trade for me into [----]. Very attractive from current levels. $VERA - will be a top trade for me into [----]. Very attractive from current levels" [X Link](https://x.com/Biotechnerd1/status/2008896067501244449) 2026-01-07T13:38Z [----] followers, [----] engagements "@Biotech2k1 Thanks & appreciate your perspective Im just watching for now post the big run. Took the gain last year" [X Link](https://x.com/Biotechnerd1/status/2008898539322065112) 2026-01-07T13:48Z [----] followers, [---] engagements "$DNLI - possibly a very good entry. At Some point this will get moving. Top Watch for me. Starter in the rollover. Curl on Daily👀" [X Link](https://x.com/Biotechnerd1/status/2008948932261339136) 2026-01-07T17:08Z [----] followers, [---] engagements "$DNLI - top run up for me in the coming months. Will let technicals guide but this one is quietly moving higher. Dont miss this one" [X Link](https://x.com/Biotechnerd1/status/2011814993067471085) 2026-01-15T14:57Z [----] followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@Biotechnerd1 BioPulse
BioPulse posts on X about $xbi, $vktx, strong, key the most. They currently have [-----] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.
Engagements: [---] #
- [--] Week [---] -82%
- [--] Month [-----] -79%
- [--] Months [-------] -93%
- [--] Year [----------] -42%
Mentions: [--] #
- [--] Month [--] -96%
- [--] Months [---] +111%
- [--] Year [---] +418%
Followers: [-----] #
- [--] Week [-----] no change
- [--] Month [-----] +0.94%
- [--] Months [-----] +29%
- [--] Year [-----] +134%
CreatorRank: [---------] #
Social Influence
Social category influence stocks 28.04% finance 10.28% cryptocurrencies 4.67% countries 1.87% currencies 1.87% exchanges 0.93%
Social topic influence $xbi #33, $vktx #54, strong 13.08%, key 8.41%, $lly 6.54%, in the 6.54%, data 6.54%, $capr 6.54%, $urgn 5.61%, $pgen 4.67%
Top accounts mentioned or mentioned by @wallstreet_dawg @seckennedy @maximusholla @sheffstation @kobeissiletter @62 @100mg @pharmdca @classicequity @ripster47 @duedoctor @martinshkreli @adamfeuerstein @vaxstolemyboy @oceanblues99 @rpsagainsttrump @elaineywchen @vipshefftrades @50ma @scroogecapital
Top assets mentioned Viking Therapeutics, Inc (VKTX) Eli Lilly and Company (LLY) Liquidia Corporation Common Stock (LQDA) Novo-Nordisk (NVO) Arcutis Biotherapeutics, Inc. (ARQT) Day One Biopharmaceuticals, Inc. (DAWN) Unicycive Therapeutics, Inc. (UNCY) Mist (MIST) Merck & Co., Inc. (MRK) Gilead Sciences, Inc. (GILD) Scholar Rock Holding Corporation Common Stock (SRRK) Cytokinetics Inc. (CYTK) Pfizer, Inc. (PFE) Structure Therapeutics Inc. (GPCR) Aligos Therapeutics, Inc. (ALGS) BridgeBio Pharma, Inc. Common Stock (BBIO) Biomea Fusion, Inc. (BMEA) Soleno Therapeutics, Inc. Common Stock (SLNO) Synthetify (SNY) Nuvation Bio Inc. (NUVB) LENZ Therapeutics Inc (LENZ) PTC Therapeutics, Inc. (PTCT) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Agios Pharmaceuticals, Inc. (AGIO) Crinetics Pharmaceuticals, Inc. (CRNX) Amgen, Inc. (AMGN) AstraZeneca PLC (AZN) Denali Therapeutics Inc. Common Stock (DNLI) Cingulate Inc. (CING) Harmony Biosciences Holdings, Inc. (HRMY) Taraxa (TARA) Taysha Gene Therapies, Inc. (TSHA) OS Therapies Incorporated (OSTX) Kyverna Therapeutics, Inc. (KYTX) Pharming Group N.V. (PHAR) Invivyd, Inc. (IVVD) Iovance Biotherapeutics, Inc. Common Stock (IOVA)
Top Social Posts
Top posts by engagements in the last [--] hours
"Key drivers of why $XAIR closed down 51% today.😑 do you agree [--]. Revenue Guidance Revised Lower: Lower Revenue Guidance FY [----] revenue guidance was revised down from $12-16 million to greater than $10 million signaling lower expected revenue growth. [--]. High Cash Burn and Financial Losses: - Increased Net Loss: The company reported a significant net loss of $60.2 million for FY [----] higher than the previous year's loss of $55.8 million. - High Cash Burn Rate: Adjusted cash burn for FY [----] was $46.2 million indicating substantial ongoing financial outflows. [--]. Capital Conservation Strategy:"
X Link 2024-06-25T22:48Z [----] followers, [----] engagements
"Dip buy opportunity in $VKTX this morning on the shameless $PFE PR. Have to wonder about this management team - no details and clear pump. No wonder stock performance has been woeful Future is about safety/tolerability/ease of use - massive 🚩🚩when these details are not disclosed"
X Link 2024-07-11T13:37Z [----] followers, [---] engagements
"WOW 👇 6.8% + this tolerability = huge win. $VKTX $VKTX Phase [--] Trial of Oral VK2735 in Healthy Subjects showing similar GI tolerability to placebo across all dose escalations up to 100mg 🔥 https://t.co/ht0m91gw9N $VKTX Phase [--] Trial of Oral VK2735 in Healthy Subjects showing similar GI tolerability to placebo across all dose escalations up to 100mg 🔥 https://t.co/ht0m91gw9N"
X Link 2024-11-04T01:48Z [----] followers, [----] engagements
"Hugely important chart below for $VKTX investors and potentially the icing on the cake. If Im reading correctly the chart indicates that VK2735 not only induces significant weight loss(6.8% placebo adjusted @100mg) by Day [--] but also supports weight maintenance over the following [--] days (up to Date 57) without additional dosing. Strong 💪🏼💪🏼💪🏼 . $VKTX $XBI $LLY $NVO @Pharmdca $VKTX This is very good. Wt loss maintained long after last dose https://t.co/bCKhla2kEm $VKTX This is very good. Wt loss maintained long after last dose https://t.co/bCKhla2kEm"
X Link 2024-11-04T02:04Z [----] followers, [----] engagements
"@ClassicEquity Higher net loss versus expectations but looks like its driven by a one off. Growth story here continues to over deliver (FY and Quarter)- Piper had a $40 price target on a lower revenue deliver versus what came in. Definitely an OPP here in the s**tty market. $DAWN"
X Link 2025-02-25T21:29Z [----] followers, [---] engagements
"Ive been reflecting on Biotech ( $XBI ) and catalyst-driven trades year-to-date. Its stating the obvious but for 95% of Biotech investors buying and holding has been nothing short of a disaster. Unless you have infinite capital and can average in over timehoping that 40% of your trades eventually deliver 5x returnsyoull struggle. Thats the reality for most investors in this sector. Im planning to deploy an existing day trading technical system to enable sharper execution using the @ripster47 approach across Biotech and the broader market. Have reviewed recent $ tickers/my normal A+ setups and"
X Link 2025-05-11T18:48Z [----] followers, [----] engagements
"$CING - another one I wish they would just get the offering/financing out of the way"
X Link 2025-12-02T20:16Z [----] followers, [---] engagements
"A few Cantor high conviction names to add to your watchlist this year. I especially like the Cantor names to run-up into key catalysts $CABA $TARA $TSHA $TRVI $GPCR $HRMY Names to watch👀. Truthfully Im not convinced on $GPCR but doesnt mean it wont move into key catalysts. https://twitter.com/i/web/status/2009465845336924338 https://twitter.com/i/web/status/2009465845336924338"
X Link 2026-01-09T03:22Z [----] followers, [---] engagements
"$ALGS - another micro cap to watch. Data on November 7th - has made big moves before"
X Link 2025-10-07T16:35Z [----] followers, [---] engagements
"$UNCY - stating cash runway into [----]. Translation = theyve been tapping that ATM hard😂 Interesting one here once it settles. Top Watch today but it might sell off in the short term"
X Link 2025-12-29T12:11Z [----] followers, [---] engagements
"$OSTX - going to raise cash before or after NDA filing Smart if they just get it done now. These names have been on 🔥when cash position is ok. Before After No Raise Before After No Raise"
X Link 2026-01-08T19:53Z [----] followers, [---] engagements
"I sold $UNCY for a solid gain yesterday. Immediately regretted it and bought back this morning. Will add this on dips"
X Link 2026-01-15T14:54Z [----] followers, [---] engagements
"$ARGX - curl watch on daily👀. Have been waiting to buy a starter in this one"
X Link 2026-01-16T13:16Z [----] followers, [---] engagements
"$KYTX - another opportunity here IMO at this level"
X Link 2026-01-29T16:19Z [----] followers, [---] engagements
"$PHAR - CRL"
X Link 2026-02-01T20:50Z [----] followers, [----] engagements
"$IVVD - a lot of upside from here if the trial goes to plan + positive results. One to watch through 2026"
X Link 2026-02-03T13:46Z [----] followers, [---] engagements
"Latest 💲 Long Positions in Order of Size(sharing high conviction only). Currently 30% ish cash. [--]. $VKTX - weight loss big bet. Have added more on any dips below $60. Added more today @62. Watch for surprise news of NASH partnership/spin off and expected weight loss benefit from oral candidate with favorable tolerability. [--]. $LXRX - Still a large spot. Made a solid move from $1.50. Not quite the run I was hoping for but more potential this week. Notes next week so dont hold unless you want to take risk through event. Took some gains. Also has data in Q125 communicated this week. [--]. $APLS -"
X Link 2024-10-22T23:11Z [----] followers, [----] engagements
"$VKTX We think that monthly dosing is very feasible - data to support this to be included in upcoming poster. $XBI"
X Link 2024-10-23T20:57Z [----] followers, [----] engagements
"$VKTX We did dose up to 100mg - we will leave results to poster. We look forward to getting the Phase [--] underway"
X Link 2024-10-23T21:03Z [----] followers, [----] engagements
"There was never a recommendation to discontinue based on tolerability. 100mg. $VKTX $VKTX We did dose up to 100mg - we will leave results to poster. We look forward to getting the Phase [--] underway $VKTX We did dose up to 100mg - we will leave results to poster. We look forward to getting the Phase [--] underway"
X Link 2024-10-23T21:05Z [----] followers, [---] engagements
"Latest YTD performance (95%+ Biotech Focused Trades Small/Mid Cap). Just 🙏🏻 for XBI / Biotech acceleration from November and catalyst trading gets very interesting at that point😌. $XBI #investingideas"
X Link 2024-10-25T22:09Z [----] followers, [----] engagements
"$URGN - will be adding on this 50MA break if it can close well. Love this name into next year - Big Catalyst ahead"
X Link 2024-10-30T18:20Z [----] followers, [---] engagements
"So if Im reading the charts correctly 100% of the 100mg cohort (n=9) achieved 5% weight loss. At a placebo adjusted loss of 6.8%. Home Run $VKTX $XBI"
X Link 2024-11-04T01:39Z [----] followers, [----] engagements
"Is a picture available of the sub q poster $VKTX"
X Link 2024-11-04T02:36Z [----] followers, [---] engagements
"$BBIO quick summary of Press Release this morning: ✅(Potential FDA approval imminent). Acoramidis (near complete TTR stabilizer for ATTR-CM): The ATTRibute-CM Phase [--] study demonstrated significant survival and quality-of-life improvements positioning it as a unique disease-modifying treatment in ATTR-CM. The NDA has been filed with a PDUFA date set for November [--] [----] signaling potential FDA approval. Upon approval the company will provide U.S. trial patients with lifelong access to acoramidis. ✅Encaleret for ADH1 has completed screening with enrollment completion expected by year-end."
X Link 2024-11-12T13:01Z [----] followers, [----] engagements
"@DueDoctor $URGN $VKTX $ATRA(short term)"
X Link 2024-11-16T21:28Z [----] followers, [----] engagements
"$BBIO Approved"
X Link 2024-11-23T00:09Z [----] followers, [----] engagements
"$SAVA - corporate update tomorrow. Its a good thing for Biotech for this one to bite the dust. Many real companies with real pipelines with real potential - this is not one of them. 💀 imminent. $XBI"
X Link 2024-11-25T01:13Z [----] followers, [----] engagements
"$SAVA #FAIL 🪦 - @MartinShkreli did his best to warn people and even the detailed work showing very clearly why it couldnt succeed. If you base your decisions on 1% what ifs in Biotech its the 100% guaranteed way to lose. $XBI"
X Link 2024-11-25T12:30Z [----] followers, 27K engagements
"$APLT 👀 - there was a question of whether the cancelled Adcomm was good or bad. If bad they probably would have raised extra $$$ by now. Strong PDUFA run up is a positive indicator too. Could see a nice 20-30% pop on approval. Not a great cash runway(mid 2025) so I do expect a raise on approval. Circa $75-100mln. 👉As of September [--] [----] Applied Therapeutics reported the following cash position and financial details: ✅Cash Cash Equivalents and Short-Term Investments: $98.9 million ✅This represents a significant increase from $49.9 million as of December [--] [----]. Runway Assessment:"
X Link 2024-11-26T15:51Z [----] followers, [----] engagements
"$APLT is going to crash hard. $2 likely. Credit to those who called out red flags and expected a CRL - market was completely off on this $XBI $APLT 👀 - there was a question of whether the cancelled Adcomm was good or bad. If bad they probably would have raised extra $$$ by now. Strong PDUFA run up is a positive indicator too. Could see a nice 20-30% pop on approval. Not a great cash runway(mid 2025) so I do expect a $APLT 👀 - there was a question of whether the cancelled Adcomm was good or bad. If bad they probably would have raised extra $$$ by now. Strong PDUFA run up is a positive"
X Link 2024-11-27T21:12Z [----] followers, [----] engagements
"Bought a decent chunk of $IOVA here"
X Link 2024-12-12T16:03Z [----] followers, [----] engagements
"$BMEA - quite a few red 🚩🚩🚩. Will post shortly"
X Link 2024-12-17T13:25Z [----] followers, [----] engagements
"$BMEA 🚩🚩🚩🤮 Anytime I see sub-group analysis its almost always a massive short signal 😑 - Clinical hold disrupted dosing continuity. - Efficacy analysis limited to a smaller subgroup. - Results driven by specific subtypes (SIDD) rather than general T2D patients. - Moderate HbA1c reductions compared to competitors. - Limited understanding of long-term durability (12-week dosing). - Cash runway risk ahead of 52-week readout. $BMEA - quite a few red 🚩🚩🚩. Will post shortly. $BMEA - quite a few red 🚩🚩🚩. Will post shortly"
X Link 2024-12-17T13:44Z [----] followers, [----] engagements
"🚨Reasons to like $PGEN🚨 ✅PDUFA Action date by June 30th 25👀 ✅Large recent insider buy $19mln👀 ✅Cash runway to [--] with recent PP👀 ✅High Private Equity & Institutional 💰👀 ✅Watch for 50MA close with volume👀 ✅Strong Analyst Coverage. JMP = $5👀 ✅Upside Downside. $1.50 likely👀 Definitely a strong run up contender into mid-2025 Can see this reaching $1.50-$2 pre PDUFA. $XBI Agree Yes 👍 Nope 👎 Yes 👍 Nope 👎"
X Link 2024-12-30T15:22Z [----] followers, [---] engagements
"$ABEO - quite a de-risked PDUFA play into next year. Eyeing up an options trade on this one. Will share soon"
X Link 2024-12-30T16:39Z [----] followers, [---] engagements
"$PGEN is on 🔥🔥🔥. $XBI 🚨Reasons to like $PGEN🚨 ✅PDUFA Action date by June 30th 25👀 ✅Large recent insider buy $19mln👀 ✅Cash runway to [--] with recent PP👀 ✅High Private Equity & Institutional 💰👀 ✅Watch for 50MA close with volume👀 ✅Strong Analyst Coverage. JMP = $5👀 ✅Upside 🚨Reasons to like $PGEN🚨 ✅PDUFA Action date by June 30th 25👀 ✅Large recent insider buy $19mln👀 ✅Cash runway to [--] with recent PP👀 ✅High Private Equity & Institutional 💰👀 ✅Watch for 50MA close with volume👀 ✅Strong Analyst Coverage. JMP = $5👀 ✅Upside"
X Link 2024-12-30T19:09Z [----] followers, [---] engagements
"Final Year P&L from main account(95% + Biotech Trades). Best ever year in absolute $ value (not %😌). Happy in the context of an $XBI that has really underperformed again. 🤞🏽 next year we finally see 🎇. A lot of learnings to take into [----]. Some applied this year but as always can be much better. Making the most of the A+ setups / historically repeatable setups that consistently pay is the most important area for me to focus next year 👀👀. Latest YTD performance (95%+ Biotech Focused Trades Small/Mid Cap). Just 🙏🏻 for XBI / Biotech acceleration from November and catalyst trading gets"
X Link 2024-12-30T19:35Z [----] followers, [----] engagements
"$VSTM - PDUFA confirmed for June 30th. Has about [--] months left of cash. Raise soon"
X Link 2025-01-02T23:55Z [----] followers, [---] engagements
"$1 Billion Biotech PDUFA stocks institutional ownership ranked by % and absolute $$$. (source: Nasdaq) Important metric to consider in terms of the potential of the catalyst👀 ability to rebound from a sell the news reaction to an approval. Lower can also mean higher risk of CRL but not always true. Good news in that there are already a lot of solid PDUFA stock catalysts to look forward to in H1 [----] Few names I want to own after a deeper dive: $ABEO $ALDX $URGN $SCPH $KALV but keeping a close eye on all. $KALV 98% $URGN 86% $SCPH 74% $LENZ 68% $ABEO 66% $ALDX 62% $VSTM 60% $INDV 58% $MIST"
X Link 2025-01-04T14:14Z [----] followers, [---] engagements
"$JSPR - went up 50% this morning before crashing $10. Safety issues and lack of detail driving the reaction Key 🚩🚩🚩 below: [--]. 🚩Small Sample Sizes Several cohorts (e.g. 240mg single-dose cohort) have very small sample sizes (N=3). While the data appears positive such small numbers limit the statistical significance and generalizability of results. Small sample sizes can exaggerate effects or underrepresent variability in outcomes. [--]. 🚩Lack of Placebo-Controlled Comparison in Some Data While some data comparisons to placebo are included other key data (e.g. durability of responses or"
X Link 2025-01-08T13:06Z [----] followers, [----] engagements
"@Maximus_Holla Looks real but want to see PR by morning"
X Link 2025-01-29T23:18Z [----] followers, [---] engagements
"$XFOR - heres the investor relations response on potential Reverse Split. The highlighted section was made by their IR team/ not me. Few ways of looking at this - [--]. Should get some clarity on RS by Feb 10th - near term risk here on this point [--]. If there is indeed a buyout offer possible this will be communicated in near term too given this deadline [--]. Also possibility of [---] day grace period as highlighted by Daniel Ferry in XFORs IR team below (most likely) $XBI"
X Link 2025-02-04T13:42Z [----] followers, [----] engagements
"🚨 $SCPH - very cheap here. Under the radar and oversold. Could see 50% move over next [--] days👀🚨 CEO today with Oppenheimer: We feel really confident And. We are fully anticipating approval on March 6th Other key points: Investment Highlights: 1.Strong Commercial Launch of FUROSCIX Q4 [----] Revenue: $12.1M - $12.3M Full Year [----] Revenue: $36.1M - $36.3M 2.Strong Financial Position Cash & Cash Equivalents: $75.5M as of year-end [----] 3.Robust Patent Protection FUROSCIX Infusor: Patent until [----] SCP-111 Autoinjector: Patent until [----] 4.Long-Term Growth Initiatives Class IV Heart Failure: FDA"
X Link 2025-02-12T23:11Z [----] followers, [----] engagements
"$DAWN - Q4 revenue of $29 million on the higher end of estimates. Not sure why stock is down right now. opportunity"
X Link 2025-02-25T21:10Z [----] followers, [----] engagements
"$PHRRF - Q2 PDUFA and approval likely👀"
X Link 2025-03-03T13:07Z [----] followers, [---] engagements
"$CAPR - exactly [--] days since BLA submission. News on Priority Review and PDUFA confirmation should be imminent👀. This one is cheap $XBI"
X Link 2025-03-03T13:12Z [----] followers, [----] engagements
"$CAPR - BLA accepted with Priority Review August PDUFA - one to watch post carnage Should bounce strong off this news. $CAPR - exactly [--] days since BLA submission. News on Priority Review and PDUFA confirmation should be imminent👀. This one is cheap $XBI $CAPR - exactly [--] days since BLA submission. News on Priority Review and PDUFA confirmation should be imminent👀. This one is cheap $XBI"
X Link 2025-03-04T12:05Z [----] followers, [----] engagements
"$PHRRF - PDUFA of June 4th. Could be interesting here from capitulation levels"
X Link 2025-03-11T12:07Z [----] followers, [---] engagements
"Having a nibble here this morning - top picks for a move: $KALV $CAPR $VSTM $URGN $MIST $ABEO $PHRRF(lottery) $XBI - time for a bounce 🙏🏻"
X Link 2025-03-12T13:51Z [----] followers, [----] engagements
"$CAPR will take off soon. Key from earnings: cash balance of approximately $152 million at year-end [----] expected to support current planned operations into [----] - huge priority review PDUFA catalyst for the company in August. Really like the entry at these levels. Prediction: despite the shit market this will at least hit its [--] week high($23.40) prior to the event. Long $XBI"
X Link 2025-03-19T22:01Z [----] followers, [----] engagements
"Fk it - added more $ABEO. Really think this is a bargain here - approval incoming and it could come early. $XBI"
X Link 2025-03-26T14:46Z [----] followers, [---] engagements
"Ive added to my $SLNO position. Approval likely so sold some Puts ahead of decision - will take nice premium if this goes as expected. Also added stock in rollover.🤞🏽 could be pivot time for $XBI. I will remain optimistic despite the carnage - this is when the real opportunities emerge. 😂😂"
X Link 2025-03-26T16:49Z [----] followers, [----] engagements
"$50k starter in $VKTX. Way way off highs. This should run into P2 data. News was positive this morning"
X Link 2025-03-26T17:05Z [----] followers, [---] engagements
"$PHRRF - still very under the radar. +RFK this could get some Press attention next few months. Worth watching. I do hold a long spot. PDUFA upcoming"
X Link 2025-03-27T14:51Z [----] followers, [----] engagements
"$CAPR - another buying opportunity here. This is going higher eventually. Cantor Reiterates Maintains $30 PT $CAPR & HCW at $77 PT. PDUFA Aug [--]. OLE study to be used for label extension. In NON-AMBULATORY patients there has been sig progress (n=12) imo. Nippon partnership in US Japan and Europe. I'm figureing 100M in milestones on approval in Cantor Reiterates Maintains $30 PT $CAPR & HCW at $77 PT. PDUFA Aug [--]. OLE study to be used for label extension. In NON-AMBULATORY patients there has been sig progress (n=12) imo. Nippon partnership in US Japan and Europe. I'm figureing 100M in"
X Link 2025-03-27T16:14Z [----] followers, [----] engagements
"$MIST leak - I dont see anything yet on wires"
X Link 2025-03-27T20:06Z [----] followers, [----] engagements
"$MIST - circa $1.30 cash per share. This one is going to fall hard today. An opportunity in the future when they sort out CMC issues but not in the immediate term - would avoid"
X Link 2025-03-28T11:18Z [----] followers, [----] engagements
"📣Summary of where we are with $SWTX $XBI + The Unknowns👀 ex Merck K. [--] weeks since the Merck letter. Normally I would think thats a bad thing but in this case I think it may in fact be a good thing Strong likelihood of multiple parties involved IMO. Note: ✅Key Positive Indicators of a Multi-Bidder Scenario -Merck Confirmed Talks Publicly (Feb 10): -Merck KGaA acknowledged active acquisition discussions with SpringWorks. -The company confirmed no binding deal had been signed leaving room for competition. ✅Strong Strategic Appeal: -SpringWorks has two FDA-approved drugs: Ogsiveo (desmoid"
X Link 2025-03-28T23:58Z [----] followers, [----] engagements
"$ALDX here we go. please be + and on time🙏🏻"
X Link 2025-04-02T19:57Z [----] followers, [----] engagements
"@KobeissiLetter April 9th Liberation Day:"
X Link 2025-04-06T14:47Z [----] followers, 10.7K engagements
"@adamfeuerstein What time do the Boston bars open"
X Link 2025-04-06T22:27Z [----] followers, [----] engagements
"@SecKennedy So will you encourage American families to get vaccinated so this doesnt happen"
X Link 2025-04-07T01:03Z [----] followers, 26.6K engagements
"@VaxStoleMyBoy @SecKennedy I think he needs to be more explicit and not reactive only to death- its already too late for many"
X Link 2025-04-07T01:21Z [----] followers, [---] engagements
"@OceanBlues99 @SecKennedy Not that you are going to listen but facts still matter Unvaccinated people are: 20x more likely to be hospitalized 10x more likely to die from measles The number of loony toons in this chat feed says it all"
X Link 2025-04-07T01:31Z [----] followers, [----] engagements
"@RpsAgainstTrump Winning - The Made in America Trump Calculator for Sale Soon"
X Link 2025-04-07T06:31Z [----] followers, [----] engagements
"Would keep an eye on $ALGS / looking for a nice strong Green volume candle. Last time this led to a large momentum move higher. From capitulation levels even a fraction of this would be good. Low floater with catalysts ahead WAY below cash. Good R:R here.$XBI"
X Link 2025-04-22T19:09Z [----] followers, [---] engagements
"$SGMO - one to watch with strong analyst coverage & $LLY factor. Its down so much after hours because of offering and limited 💵 runway. Possibly an interesting oversold bounce play tomorrow with data catalyst upcoming. They will need more financing before BLA filing - strength of that comes down to data 🧑🔬Fabry Disease (Lead Program): All patients in Phase 1/2 STAAR trial (isaralgagene civaparvovec) have completed the 52-week FDA-required follow-up. Positive eGFR trends maintained; well tolerated. Productive CMC meeting with FDA in April [----]. Target BLA submission: Q1 [----] Potential"
X Link 2025-05-12T22:38Z [----] followers, [----] engagements
"Yikes $SGMO - no floor 😱 $SGMO - one to watch with strong analyst coverage & $LLY factor. Its down so much after hours because of offering and limited 💵 runway. Possibly an interesting oversold bounce play tomorrow with data catalyst upcoming. They will need more financing before BLA filing - $SGMO - one to watch with strong analyst coverage & $LLY factor. Its down so much after hours because of offering and limited 💵 runway. Possibly an interesting oversold bounce play tomorrow with data catalyst upcoming. They will need more financing before BLA filing -"
X Link 2025-05-12T22:44Z [----] followers, [----] engagements
"This is actually very bullish for $VKTX - right - $NVO planning to fork out 2.2bln. $VKTX sitting at a 3.1bln market cap and at completely different advanced development stage On watch today Novo Nordisk $NVO strikes deal with Septerna $SEPN to develop obesity pills https://t.co/95Ixvy9Ywr via @elaineywchen Novo Nordisk $NVO strikes deal with Septerna $SEPN to develop obesity pills https://t.co/95Ixvy9Ywr via @elaineywchen"
X Link 2025-05-14T11:38Z [----] followers, [----] engagements
"🚨 $URGN - Docs Out. Summary Whats the view here - trial design a big issue Key Positives ✅ Strong Efficacy 77.6% CRR at [--] months 79% maintained response at [--] months 🧓 Patient Preference Older/comorbid patients prefer UGN-102 over TURBT Less invasive office-based treatment 🏥 In-Office Option Offers non-surgical alternative Reduces anesthesia risk Key Negatives ⚠ No Control Arm Single-arm ENVISION trial = weak comparative data Hard to separate drug effect from natural history ❌ Incomplete PRO Data Patient-reported urinary symptoms not robustly captured FDA says timing/methods flawed 💉"
X Link 2025-05-16T12:38Z [----] followers, [----] engagements
"🚨Part [--] - Latest PDUFA/Adcomm dates [--] days 👀. Note - I always like to prioritize based on timing. Especially when the $XBI is weak $NVAX - Approved this weekend $URGN AdComm May [--] $ARQT May [--] $SNY May [--] $LQDA May [--] $ETON May [--] $MRNA May [--] $MRK June [--] $MRNA June [--] $URGN June [--] $GILD June [--] $REGN $SNY June [--] $MRK June [--] $NUVB June [--] $UNCY June [--] $REGN July [--] $AZN $DSNKY July [--] $REPL July [--] $GSK July [--] $ASND July [--] $APLS July [--] $REGN $ZLAB July 30"
X Link 2025-05-18T20:05Z [----] followers, [----] engagements
"🚨Part [--] [--]. For missing $ tickers please comment 🙏🏻: $GRPH $LENZ $PHRRF Aug [--] [--] $INSM Aug [--] $TNXP Aug [--] $CMRX $ABEO $RARE Aug [--] $PTCT Aug [--] $IONS $THTX Aug [--] $PGEN Aug [--] $OTLK Aug [--] $SNY Aug [--] $CAPR Aug [--] $BIIB Aug [--] $AGIO - Sep 7th $BCRX Sep [--] $SRRK Sep [--] $MRK - Sep [--] $OMER Sep [--] $CRNX - Sep [--] $FBIO Sep [--] $ARQT Oct [--] $AMGN $AZN Oct [--] $GKOS Oct [--] $RHHBY Oct [--] $RGNX Nov [--] $ARWR Nov [--] $AMGN Dec [--] $CYTK Dec [--] $CORT Dec [--] $VNDA Dec [--] $TVTX Jan [--] $VNDA Feb [--] $BHVN AdComm + PDUFA Q4 2025+ (TBD)"
X Link 2025-05-18T20:35Z [----] followers, [----] engagements
"$REPL - one to watch. July PDUFA - no Adcomm"
X Link 2025-05-22T12:40Z [----] followers, [----] engagements
"$ARQT approved"
X Link 2025-05-22T18:16Z [----] followers, [---] engagements
"📚Weekend PDUFA Homework 📚 Action Packed Catalyst Filled YTG with XBI near lows. Cant remember so many PDUFAs Caution needed in short term but there are names below that will 2X + pre catalyst. Need to find them👀. $XBI $IBB Please point out any gaps or ideas"
X Link 2025-05-25T13:36Z [----] followers, [----] engagements
"Here are the ➕📈 Momentum names bucking the sector trend from this list. As you can imagine its short 😂. Only names Id be comfortable buying and holding right now over few months. With stops at key support If we see a rocky few weeks these could be very good names to buy. 🟢 $CORT 🟢 $BCRX 🟢 $DSNKY 🟢 $GILD 🟢 $ASND 🟢 $ZLAB 🟢 $LENZ 🟢 $TNXP 🟢 $ABEO 🟢 $THTX $XBI $IBB 📚Weekend PDUFA Homework 📚 Action Packed Catalyst Filled YTG with XBI near lows. Cant remember so many PDUFAs Caution needed in short term but there are names below that will 2X + pre catalyst. Need to find them👀. $XBI"
X Link 2025-05-25T15:17Z [----] followers, [----] engagements
"Here is my Bounce List - names that could reverse soon and bounce in a green-flat $XBI 👀 🟧 $SRRK 🟧 $KALV 🟧 $AZN 🟧 $PHRRF 🟧 $PTCT 🟧 $IONS 🟧 $PGEN 🟧 $ARQT 🟧 $CHRS 🟧 $ARWR Not justified in technicals right now but could reverse soon: 🟧 $FBIO 🟧 $ICCM 🟧 $OTLK 🟧 $CAPR 🟧 $NUVB 🟧 $VNDA Here are the ➕📈 Momentum names bucking the sector trend from this list. As you can imagine its short 😂. Only names Id be comfortable buying and holding right now over few months. With stops at key support If we see a rocky few weeks these could be very good names to buy. Here are the ➕📈 Momentum"
X Link 2025-05-25T18:37Z [----] followers, [----] engagements
"Well thats a penetration rate to get excited about 📈🚀. $LLY $NVO $AMGN $PFE $VKTX $ZEAL $GPCR $RHHBY https://apple.news/AjTxTTEAWTDuh1Hk0iHw92g https://apple.news/AjTxTTEAWTDuh1Hk0iHw92g"
X Link 2025-05-26T02:53Z [----] followers, 24.6K engagements
"@KobeissiLetter Current Priority:"
X Link 2025-05-26T19:45Z [----] followers, [----] engagements
"To state the obvious $URGN approval is extremely bullish for PDUFA catalyst trades this year"
X Link 2025-06-12T18:30Z [----] followers, [---] engagements
"@Maximus_Holla Love $LRMR in particular - only a matter of time for this to 🚀"
X Link 2025-06-18T16:08Z [----] followers, [----] engagements
"Few challenges and keen to hear your thoughts. First below are some recent examples of late cycle deficiency letters that resulted in a CRL: Ascendis Pharma TransCon PTH (Hypoparathyroidism) Deficiency Letter: April [--] [----] PDUFA: April [--] [----] ❌ CRL issued Reason: Manufacturing/CMC issues with dose variability control; no clinical problems Type: NDA (Biologic) Phathom Pharma Vonoprazan (Erosive GERD) Deficiency Letter: January [--] [----] PDUFA: January [--] [----] ❌ CRL issued Reason: Nitrosamine impurity in tablets (CMC); no efficacy issues Type: NDA (Small molecule) Lexicon Pharmaceuticals"
X Link 2025-06-28T17:13Z [----] followers, [---] engagements
"$VKTX - finally break of [--] today"
X Link 2025-07-08T14:08Z [----] followers, [---] engagements
"$REVB securities lending rate at Schwab. 62% 🤯. I dont know who in the world would want to short a sub 600k float micro cap stock with a near term data catalyst. Good in terms of squeeze potential.@VIPSheffTrades @SheffStation fyi. $XBI"
X Link 2025-07-10T14:17Z [----] followers, [----] engagements
"$PGEN - another upcoming PDUFA under CBER that ran a single arm trial. Would exercise caution on this one now based on $REPL CRL"
X Link 2025-07-22T11:24Z [----] followers, [----] engagements
"$VKTX earnings tomorrow Should be a good clearing event ahead of their data - could make a nice move from tm"
X Link 2025-07-22T12:05Z [----] followers, [----] engagements
"$VKTX - data run up going to be good with this one"
X Link 2025-07-25T13:33Z [----] followers, [---] engagements
"Make that [--] big flushes - I did ⛔. $IXHL Two big flushes here [--]. On the unhalt from [----] [--]. On the open from [----]. Looks like it could go lower from here but risk reward not there anymore for me. $IXHL Two big flushes here [--]. On the unhalt from [----] [--]. On the open from [----]. Looks like it could go lower from here but risk reward not there anymore for me. $IXHL"
X Link 2025-07-30T14:38Z [----] followers, [----] engagements
"LOL 🤡🤡🤡 $IXHL $XBI Hey folks we have been actively screwing you since yesterday but dont worry we wont utilize the FULL $100mln Make that [--] big flushes - I did ⛔. $IXHL Make that [--] big flushes - I did ⛔. $IXHL"
X Link 2025-07-31T12:04Z [----] followers, [----] engagements
"$LLY - this drop way overdone👀. Funny close to a $100bln drop in market cap. Sure they could just buy $VKTX for a rounding error and their market cap would recover/go higher😂"
X Link 2025-08-07T10:46Z [----] followers, [----] engagements
"Good Morning🌅 Top [--] Watch for me today👀 $VKTX - oral data soon & $LLY 🤢 pill data $GILD - 💪🏼 earnings. New ATH $CYTK - @50MA. Post earnings. Could push now. PDUFA December. $NVO - oversold bounce. $ETON - big move already PM but strong momentum name in the past. $SRRK - PDUFA Sept 22nd. Oversold. $KURA - Earnings Clearing Event. Multiple Catalysts ahead including PR PDUFA. $LLY - watching. Could go either way - think this bounces soon. $AKRO - no buyout. May sell off. $IOVA - will likely be a big mover either way on open. New ATL $XBI $IBB"
X Link 2025-08-08T11:26Z [----] followers, [----] engagements
"$LQDA - super strong. Has blown past expectations - a lot of upside. I was skeptical here for a while. Follow the numbers . this one should do well👀"
X Link 2025-08-12T10:38Z [----] followers, [----] engagements
"Just to put this into perspective I think $LQDA have hit circa 90% of Oppenheimers total expectation in11 weeks. The upper analyst targets of $40 + look very realistic now.upgrades should follow. $XBI $LQDA YUTREPIA surpasses [---] unique patient prescriptions and [---] patient starts within [--] weeks after approval to treat PAH and PH-ILD https://t.co/sZdo9fucDa $LQDA YUTREPIA surpasses [---] unique patient prescriptions and [---] patient starts within [--] weeks after approval to treat PAH and PH-ILD https://t.co/sZdo9fucDa"
X Link 2025-08-12T10:52Z [----] followers, [----] engagements
"Buying a starter here pre market @$22.80. Want to see open but this could do very well today. $LQDA Just to put this into perspective I think $LQDA have hit circa 90% of Oppenheimers total expectation in11 weeks. The upper analyst targets of $40 + look very realistic now.upgrades should follow. $XBI Just to put this into perspective I think $LQDA have hit circa 90% of Oppenheimers total expectation in11 weeks. The upper analyst targets of $40 + look very realistic now.upgrades should follow. $XBI"
X Link 2025-08-12T11:20Z [----] followers, [----] engagements
"@scroogecapital The management /execution did indeed change my mind - check my feed. Ive been bullish on this for a while. also clearly as a long term short idea I was wrong - so wrong I went long myself and posted as such. no issues admitting when Im wrong 😌 $LQDA"
X Link 2025-08-12T15:19Z [----] followers, [---] engagements
"$TNXP - where is the news"
X Link 2025-08-15T11:07Z [----] followers, [----] engagements
"$TNXP $60 - $14 - back over $40😂😂 I did say today would be fun. $TNXP - where is the news $TNXP - where is the news"
X Link 2025-08-15T11:10Z [----] followers, [----] engagements
"Bio Catalyst names going to be 🔥 - with rate cuts coming. This has happened before"
X Link 2025-08-22T14:06Z [----] followers, [---] engagements
"Good Morning 🌅 - heres my top [--] focus Biotech names for today: $OTLK - Decision day. Pop & Drop watch if approved. $GRCE - PDUFA April [----]. $SLNO - Bounce watch off MA. Like this to make a big move soon. $LLY - Oral Submission coming. Huge catalyst. $LRMR - Data [--] days. $CRNX - PDUFA [--] days. $AGIO - PDUFA [--] days. $MNKD - Oversold. Volume Pre Market $DAWN - Turnaround story from slow start A lot of upside if management deliver. $CYTK - PDUFA top Watch. Others Im keeping an eye on: $XFOR $BBIO $BHVN $LQDA. Short: $BTAI(its mostly played out pre market) $TNXP (classic post approval fade)"
X Link 2025-08-27T13:01Z [----] followers, [----] engagements
"$KURA $CYTK $SNDX $TVTX - top PDUFA catalyst picks 😍"
X Link 2025-08-28T14:04Z [----] followers, [----] engagements
"$CYTK - that inevitable buyout rumor will drop sometime soon. Probably pushes it over $60 when that happens. Also a good entry here. Very very de risked now moving forward. $XBI"
X Link 2025-09-04T17:48Z [----] followers, [----] engagements
"I really like $ALDX as a bounce play from $4. Extension and should get approval. 50% upside into PDUFA"
X Link 2026-01-06T16:31Z [----] followers, [----] engagements
"$VERA touched [--] a pre market ATH - up well over 100% from that silly dip to [--] a few months back. $VERA - will be a top trade for me into [----]. Very attractive from current levels. $VERA - will be a top trade for me into [----]. Very attractive from current levels"
X Link 2026-01-07T13:38Z [----] followers, [----] engagements
"@Biotech2k1 Thanks & appreciate your perspective Im just watching for now post the big run. Took the gain last year"
X Link 2026-01-07T13:48Z [----] followers, [---] engagements
"$DNLI - possibly a very good entry. At Some point this will get moving. Top Watch for me. Starter in the rollover. Curl on Daily👀"
X Link 2026-01-07T17:08Z [----] followers, [---] engagements
"$DNLI - top run up for me in the coming months. Will let technicals guide but this one is quietly moving higher. Dont miss this one"
X Link 2026-01-15T14:57Z [----] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing